NASDAQ : ASBP
Aspire Biopharma Holdings, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 8.11 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 11.37M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Aspire Biopharma Holdings, Inc. (ASBP) reported revenue of 97.66K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 97.66K | 6.20K | |||
| Cost of Revenue | 122.11K | 6.32K | |||
| Gross Profit | -24.45K | -116.00 | |||
| Selling, General & Admin | -7.90M | 4.30M | 1.07M | 286.54K | 421.18K |
| Research & Development | 838.14K | 923.91K | 144.36K | 72.05K | 175.32K |
| Operating Expenses | -7.07M | 5.22M | 1.21M | 358.59K | 596.49K |
| Operating Income | 7.04M | -5.22M | -1.21M | -358.59K | -596.49K |
| Interest Expense | -9.31M | -8.53M | -97.99K | ||
| Other Non Operating Income (Expenses) | 4.40M | 3.77M | |||
| EBT Excluding Unusual Items | 2.20M | -9.99M | -1.31M | -358.59K | -596.49K |
| Merger & Restructuring Charges | -14.36M | -14.13M | |||
| Other Unusual Items | 1.12M | -364.11K | |||
| Pretax Income | -11.05M | -24.48M | -1.31M | -358.59K | -596.49K |
| Income Tax Expense | 1.01K | 481.00 | 626.00 | ||
| Net Income | -11.05M | -24.48M | -1.31M | -359.07K | -597.12K |
| Net Income to Common | -11.05M | -24.48M | -1.31M | -359.07K | -597.12K |
| Shares Outstanding (Basic) | 331.48K | 49.83K | 23.00K | 443.00M | |
| Shares Outstanding (Diluted) | 331.48K | 49.83K | 23.00K | 443.00M | |
| EPS (Basic) | -33.33 | -491.27 | -56.96 | -0.00 | |
| EPS (Diluted) | -33.33 | -491.27 | -56.96 | -0.00 | |
| Gross Margin | -25.04% | -1.87% | |||
| Operating Margin | 7,210.15% | -84,167.06% | |||
| Profit Margin | -11,314.12% | -394,725.06% | |||
| EBIT | 7.04M | -5.22M | -1.21M | -358.59K | -596.49K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 12.17M | 1.00M | 3.63K | 11.17K | 38.00 |
| Cash & Short-Term Investments | 12.17M | 1.00M | 3.63K | 11.17K | 38.00 |
| Inventory | 288.45K | 253.16K | |||
| Prepaid Expenses | 1.01M | 55.10K | 144.36K | 35.00K | 22.50K |
| Total Current Assets | 13.47M | 1.31M | 147.99K | 46.17K | 22.54K |
| Total Assets | 13.54M | 1.31M | 147.99K | 46.17K | 22.54K |
| Accounts Payable | 972.11K | 1.01M | 310.22K | 172.77K | 122.73K |
| Accrued Expenses | 714.09K | 1.36M | |||
| Short-Term Debt | 5.18M | 1.27M | 360.64K | 27.97K | |
| Other Current Liabilities | 40.95K | 111.03K | 626.00 | 626.00 | |
| Total Current Liabilities | 1.69M | 7.59M | 1.69M | 534.03K | 151.33K |
| Other Long-Term Liabilities | 96.53K | 95.66K | 1.00 | ||
| Total Liabilities | 1.78M | 7.69M | 1.69M | 534.03K | 151.33K |
| Common Stock | 129.00 | 353.00 | 69.00 | 22.00K | 221.50K |
| Additional Paid-In Capital | 43.51M | 20.88M | 1.24M | 957.50K | 758.00K |
| Retained Earnings | -31.75M | -27.26M | -2.78M | -1.47M | -1.11M |
| Shareholders' Equity | 11.76M | -6.38M | -1.54M | -487.86K | -128.79K |
| Total Liabilities & Equity | 13.54M | 1.31M | 147.99K | 46.17K | 22.54K |
| Total Debt | 5.18M | 1.27M | 360.64K | 27.97K | |
| Net Cash (Debt) | 12.17M | -4.17M | -1.26M | -349.46K | -27.93K |
| Net Cash Per Share | 36.71 | -83.71 | -54.93 | -0.00 | |
| Filing Date Shares Outstanding | 1.40M | 167.47K | 440.00M | 443.32M | |
| Total Common Shares Outstanding | 1.30M | 117.78K | 440.00M | 443.00M | |
| Working Capital | 11.78M | -6.28M | -1.54M | -487.86K | -128.79K |
| Book Value Per Share | 9.08 | -54.14 | -0.00 | -0.00 | |
| Tangible Book Value | 11.76M | -6.38M | -1.54M | -487.86K | -128.79K |
| Tangible Book Value Per Share | 9.08 | -54.14 | -0.00 | -0.00 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Net Income | -11.05M | -24.48M | -1.31M | -359.07K | -597.12K |
| Other Amortization | 9.60M | 8.02M | |||
| Stock-Based Compensation | 157.50K | 14.13M | |||
| Other Operating Activities | -6.01M | -3.13M | |||
| Change in Inventory | -330.82K | -253.16K | |||
| Change in Accounts Payable | -1.38M | -323.78K | 247.85K | 50.04K | 102.73K |
| Change in Other Net Operating Assets | 1.82M | 1.11M | 796.84K | 320.17K | 351.48K |
| Operating Cash Flow | -7.19M | -4.92M | -265.19K | 11.14K | -142.91K |
| Sale (Purchase) of Intangibles | -4.90M | ||||
| Investing Cash Flow | -4.90M | ||||
| Short-Term Debt Issued | 10.30M | ||||
| Total Debt Issued | 9.25M | 10.30M | |||
| Short-Term Debt Repaid | -3.73M | ||||
| Total Debt Repaid | -7.07M | -3.73M | |||
| Net Debt Issued (Repaid) | 2.18M | 6.57M | |||
| Issuance of Common Stock | 811.37K | 811.37K | 257.64K | 1.00M | |
| Other Financing Activities | -1.79M | -1.45M | 3.85M | ||
| Financing Cash Flow | 19.15M | 5.92M | 257.64K | 4.85M | |
| Net Cash Flow | 11.96M | 1.00M | -7.54K | 11.14K | -185.46K |
| Levered Free Cash Flow | 7.43M | 15.39M | -679.55K | -186.58K | |
| Unlevered Free Cash Flow | 3.65M | 12.70M | -618.30K | -186.58K | |
| Cash Interest Paid | 44.39K | 44.39K | |||
| Change in Working Capital | 111.15K | 533.38K | 1.04M | 370.21K | 454.21K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Market Capitalization | 11.37M | 14.18M | 89.29M | 97.91M | 370.15M |
| Enterprise Value | -792.40K | 20.85M | 89.71M | ||
| Last Close Price | 8.11 | 158.28 | 13,800.01 | 13,068.01 | 12,360.01 |
| PS Ratio | 116.47 | 2,285.75 | |||
| PB Ratio | 0.89 | -2.22 | -57.98 | -200.68 | -2,874.02 |
| P/OCF Ratio | 8,791.81 | ||||
| EV/Sales Ratio | 3,362.25 | ||||
| Debt / Equity Ratio | -0.81 | -0.82 | -0.74 | -0.22 | |
| Net Debt / Equity Ratio | -1.03 | -0.65 | -0.82 | -0.72 | -0.22 |
| Asset Turnover | 0.01 | 0.01 | |||
| Quick Ratio | 7.22 | 0.13 | 0.00 | 0.02 | 0.00 |
| Current Ratio | 7.99 | 0.17 | 0.09 | 0.09 | 0.15 |
| Return on Assets (ROA) | 60.58% | -446.87% | -779.55% | -652.34% | |
| Return on Capital Employed (ROCE) | 59.40% | 83.10% | 78.60% | 73.50% | 463.20% |
| Earnings Yield | -411.01% | -172.69% | -1.47% | -0.37% | -0.16% |
| Buyback Yield / Dilution | -1,015.92% | -116.69% | 100.00% |